Table 3. Subgroups of primary melanoma in training cohort, validation cohort and combined cohort.
Population | Subgroup | Expression | Case no. (%) |
---|---|---|---|
Training cohort (145 cases) | ML | KAI1-/P27- | 48 (33.10) |
NML | Either KAI1 or p27 is negative | 97 (66.90) | |
Validation cohort (92 cases) | ML | KAI1- P27- | 34 (37.00) |
NML | Either KAI1 or p27 is negative | 58 (63.00) | |
Combined cohort (237 cases) | ML | KAI1- P27- | 82 (34.60) |
NML | Either KAI1 or p27 is negative | 155 (65.40) |
ML, metastasis-like; NML, non-metastasis-like